SCOTTSDALE, Ariz., Oct. 11, 2016 -- TPI Composites, Inc., (TPI) (Nasdaq:TPIC), the largest U.S.-based independent manufacturer of composite wind blades, announced today that it has extended two supply agreements with General Electric International (“GE”) in Newton, Iowa and Juarez, Mexico through 2020. TPI also entered into a new agreement with GE for the supply of incremental wind blades from its third party manufacturing facility under construction in Juarez, Mexico through 2020, expecting to begin production in the first quarter of 2017.
“We are excited to extend our contracts in Mexico and Iowa and to enter into a new supply agreement in Mexico with GE. TPI and GE have always been great partners and our relationship is further strengthened by the agreements announced today,” said Steve Lockard, TPI’s President and CEO.
"As we stated today in our announcement, it’s GE’s intention to retain our ability to source blades from other suppliers. We will honor our existing contracts with TPI, and note also that we extended our existing contracts with TPI in Iowa and Mexico recently,” said Anne McEntee, President and CEO Onshore Wind, GE Renewable Energy.
About TPI Composites, Inc.
TPI Composites, Inc. is the largest U.S.-based independent manufacturer of composite wind blades for the wind energy market. TPI delivers high-quality, cost-effective composite solutions through long term relationships with leading wind turbine manufacturers. TPI is headquartered in Scottsdale, Arizona and operates factories throughout the U.S., Mexico, China and Turkey.
Investor Contact: [email protected] 480-315-8742


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



